Hoffmann-la Roche Drug Patent Portfolio
Hoffmann-la Roche owns 1 orange book drug protected by 5 US patents Given below is the list of Hoffmann-la Roche's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10350214 | Preparation containing tetracyclic compound at high dose | 24 Apr, 2035 | Active |
| US11433076 | Preparation containing tetracyclic compound at high dose | 24 Apr, 2035 | Active |
| US9365514 | Composition comprising tetracyclic compound | 04 Mar, 2032 | Active |
| US9126931 | Tetracyclic compound | 29 May, 2031 | Active |
| US9440922 | Tetracyclic compound | 09 Jun, 2030 | Active |
Latest Legal Activities on Hoffmann-la Roche's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Hoffmann-la Roche.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Feb, 2024 | US9440922 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 29 Nov, 2023 | US9365514 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Mar, 2023 | US9126931 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Jan, 2023 | US10350214 |
|
Recordation of Patent Grant Mailed
Critical
| 06 Sep, 2022 | US11433076 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 Sep, 2022 | US11433076 |
|
Email Notification
Critical
| 18 Aug, 2022 | US11433076 |
|
Issue Notification Mailed
Critical
| 17 Aug, 2022 | US11433076 |
| Dispatch to FDC | 05 Aug, 2022 | US11433076 |
|
Email Notification
Critical
| 03 Aug, 2022 | US11433076 |
| Mailing Corrected Notice of Allowability | 03 Aug, 2022 | US11433076 |
| Corrected Notice of Allowability | 29 Jul, 2022 | US11433076 |
|
Information Disclosure Statement considered
Critical
| 29 Jul, 2022 | US11433076 |
|
Pubs Case Remand to TC
Critical
| 29 Jul, 2022 | US11433076 |
| Workflow - Request for RCE - Finish | 28 Jul, 2022 | US11433076 |
Hoffmann-la Roche's Family Patents
Hoffmann-la Roche Drug List
Given below is the complete list of Hoffmann-la Roche's drugs and the patents protecting them.
1. Alecensa
Alecensa is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10350214 | Preparation containing tetracyclic compound at high dose |
24 Apr, 2035
(10 years from now)
| Active |
| US11433076 | Preparation containing tetracyclic compound at high dose |
24 Apr, 2035
(10 years from now)
| Active |
| US9365514 | Composition comprising tetracyclic compound |
04 Mar, 2032
(7 years from now)
| Active |
| US9126931 | Tetracyclic compound |
29 May, 2031
(6 years from now)
| Active |
| US9440922 | Tetracyclic compound |
09 Jun, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alecensa's drug page